• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补骨脂素加紫外线A光疗抑制致病性相关细胞中角质形成细胞衍生的趋化因子。

Bath Psoralen Plus UVA Therapy Suppresses Keratinocyte-Derived Chemokines in Pathogenetically Relevant Cells.

作者信息

Kanayama Yoshifumi, Torii Kan, Ikumi Kyoko, Morita Akimichi

机构信息

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

出版信息

JID Innov. 2021 May 24;1(3):100027. doi: 10.1016/j.xjidi.2021.100027. eCollection 2021 Sep.

DOI:10.1016/j.xjidi.2021.100027
PMID:34909726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8659370/
Abstract

Psoriasis is a chronic inflammatory proliferative skin disease involving various types of chemokines regulating immune cell migration, localization, and activation. Bath psoralen plus UVA (PUVA) treatment is an established phototherapy for psoriasis, but its effects on chemokine levels remain unknown. We investigated the levels of 22 serum chemokines in 20 patients with psoriasis first treated with bath PUVA therapy between 2007 and 2011 in a single center and analyzed the associations between the chemokines and disease severity (PASI) before and after therapy to investigate the mechanisms of action of bath PUVA therapy. Before bath PUVA therapy, the PASI scores correlated with the serum levels of CCL17 (r = 0.581), CCL18 (r = 0.462), CCL19 (r = 0.477), and CXCL16 (r = 0.524). After bath PUVA, the serum levels of CCL17, CCL22, CXCL1, and CXCL9 were significantly decreased. Heatmap clustering and network analysis based on statistically significant Spearman correlations among the chemokines showed distinctive changes in the chemokine signature. Our findings revealed that the levels of several chemokines correlated with the disease state of psoriasis. Furthermore, bath PUVA therapy reduced the secretion of keratinocyte-derived chemokines that induce the migration of immune cells important for psoriasis pathogenesis, partly revealing the mechanism of the therapeutic activity.

摘要

银屑病是一种慢性炎症性增殖性皮肤病,涉及多种调节免疫细胞迁移、定位和激活的趋化因子。沐浴补骨脂素联合紫外线A(PUVA)疗法是一种已确立的银屑病光疗方法,但其对趋化因子水平的影响尚不清楚。我们调查了2007年至2011年在单一中心首次接受沐浴PUVA治疗的20例银屑病患者的22种血清趋化因子水平,并分析了治疗前后趋化因子与疾病严重程度(银屑病面积和严重程度指数,PASI)之间的关联,以研究沐浴PUVA疗法的作用机制。在沐浴PUVA治疗前,PASI评分与CCL17(r = 0.581)、CCL18(r = 0.462)、CCL19(r = 0.477)和CXCL16(r = 0.524)的血清水平相关。沐浴PUVA治疗后,CCL17、CCL22、CXCL1和CXCL9的血清水平显著降低。基于趋化因子之间具有统计学意义的斯皮尔曼相关性进行的热图聚类和网络分析显示趋化因子特征有明显变化。我们的研究结果表明,几种趋化因子的水平与银屑病的疾病状态相关。此外,沐浴PUVA疗法减少了角质形成细胞衍生的趋化因子的分泌,这些趋化因子可诱导对银屑病发病机制重要的免疫细胞迁移,部分揭示了治疗活性的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/dcc52d9e826f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/8fb29c76586c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/55f9d4861feb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/635f5148b616/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/8cc46fba42d4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/dcc52d9e826f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/8fb29c76586c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/55f9d4861feb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/635f5148b616/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/8cc46fba42d4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ae/8659370/dcc52d9e826f/gr5.jpg

相似文献

1
Bath Psoralen Plus UVA Therapy Suppresses Keratinocyte-Derived Chemokines in Pathogenetically Relevant Cells.补骨脂素加紫外线A光疗抑制致病性相关细胞中角质形成细胞衍生的趋化因子。
JID Innov. 2021 May 24;1(3):100027. doi: 10.1016/j.xjidi.2021.100027. eCollection 2021 Sep.
2
Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.数字紫外线疗法:一种针对寻常型银屑病靶向治疗的新型治疗方法。
Br J Dermatol. 2015 Mar;172(3):746-53. doi: 10.1111/bjd.13464. Epub 2015 Jan 30.
3
Systematic review of UV-based therapy for psoriasis.基于紫外线的银屑病治疗的系统评价。
Am J Clin Dermatol. 2013 Apr;14(2):87-109. doi: 10.1007/s40257-013-0015-y.
4
Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.窄谱中波紫外线(311纳米)光疗与补骨脂素加长波紫外线光化学疗法:联合应用。
J Am Acad Dermatol. 1998 May;38(5 Pt 1):687-90. doi: 10.1016/s0190-9622(98)70214-2.
5
Bath-PUVA still represents a valuable treatment option for the subsets of psoriatic patients who are not eligible to or rejecting systemic treatments and are not responsive to NB-UVB phototherapy.水疗联合补骨脂素长波紫外线疗法对于那些不适合或拒绝接受系统治疗且对窄谱中波紫外线光疗反应不佳的银屑病患者亚群仍然是一种有价值的治疗选择。
Photodermatol Photoimmunol Photomed. 2023 Jul;39(4):351-356. doi: 10.1111/phpp.12846. Epub 2022 Dec 7.
6
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.窄谱中波紫外线与补骨脂素乳膏 - 长波紫外线联合疗法治疗斑块型银屑病。
J Am Acad Dermatol. 2004 May;50(5):734-9. doi: 10.1016/s0190-9622(03)00792-8.
7
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.香豆素光化学疗法和窄谱 UV-B 疗法治疗慢性斑块型银屑病的致癌风险:系统文献回顾。
J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:22-31. doi: 10.1111/j.1468-3083.2012.04520.x.
8
Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.补骨脂素长波紫外线疗法与窄谱中波紫外线疗法治疗慢性斑块型银屑病的疗效比较:系统文献回顾。
J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:11-21. doi: 10.1111/j.1468-3083.2012.04519.x.
9
Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.水疗联合补骨脂素光化学疗法可减少蕈样肉芽肿患者中浸润的 CCR4 表达肿瘤细胞和调节性 T 细胞。
Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):273-80. doi: 10.1016/j.clml.2012.12.002. Epub 2013 Jan 16.
10
A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.窄谱中波紫外线光疗与补骨脂素紫外线A光化学疗法应用之展望
Front Med (Lausanne). 2018 Jul 2;5:184. doi: 10.3389/fmed.2018.00184. eCollection 2018.

引用本文的文献

1
Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future.中医作为银屑病的辅助治疗:过去、现在与未来
Chin J Integr Med. 2023 Mar;29(3):280-288. doi: 10.1007/s11655-022-3683-8. Epub 2022 Oct 27.
2
Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops.通过评估皮损血滴来确定皮肤 T 细胞淋巴瘤病变中的免疫环境。
Sci Rep. 2021 Oct 4;11(1):19629. doi: 10.1038/s41598-021-98804-0.
3
The Role of Chemokines in Psoriasis-An Overview.趋化因子在银屑病中的作用——概述。

本文引用的文献

1
Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis.银屑病患者的胸腺与活化调节趋化因子(TARC):泛发性脓疱型银屑病患者血清TARC水平升高。
J Dermatol. 2020 Oct;47(10):1149-1156. doi: 10.1111/1346-8138.15511. Epub 2020 Jul 16.
2
Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22-producing skin T-cell overactivation.银屑病相关的 CCL27/CCR10 衍生调节受损导致产生 IL-17A/IL-22 的皮肤 T 细胞过度激活。
J Allergy Clin Immunol. 2021 Feb;147(2):759-763.e9. doi: 10.1016/j.jaci.2020.05.044. Epub 2020 Jun 10.
3
Medicina (Kaunas). 2021 Jul 26;57(8):754. doi: 10.3390/medicina57080754.
CCR4 Skin-Tropic Phenotype as a Feature of Central Memory CD8 T Cells in Healthy Subjects and Psoriasis Patients.
CCR4 皮肤嗜性表型是健康受试者和银屑病患者中央记忆 CD8 T 细胞的特征。
Front Immunol. 2020 Apr 3;11:529. doi: 10.3389/fimmu.2020.00529. eCollection 2020.
4
The CCL20 and CCR6 axis in psoriasis.CCL20 和 CCR6 轴在银屑病中的作用。
Scand J Immunol. 2020 Mar;91(3):e12846. doi: 10.1111/sji.12846. Epub 2019 Nov 24.
5
Correlation analysis between IL-35, IL-36, CCL27 and psoriasis vulgaris.IL-35、IL-36、CCL27 与寻常型银屑病的相关性分析。
J Dermatolog Treat. 2021 Sep;32(6):621-624. doi: 10.1080/09546634.2019.1689226. Epub 2019 Nov 20.
6
Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation.角质形成细胞衍生的 IκBζ 驱动银屑病及其相关的全身炎症。
JCI Insight. 2019 Nov 14;4(22):130835. doi: 10.1172/jci.insight.130835.
7
A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis.偏倚的驻留 T 细胞池会引发银屑病患者非皮损皮肤中的银屑病相关组织反应。
J Allergy Clin Immunol. 2019 Apr;143(4):1444-1454. doi: 10.1016/j.jaci.2018.08.048. Epub 2018 Sep 27.
8
Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.在银屑病的生物治疗过程中血清胸腺和活化调节趋化因子水平的改变:作为反映抗白细胞介素-17A 药物应答良好的标志物的可能性。
J Dermatol. 2018 Jun;45(6):710-714. doi: 10.1111/1346-8138.14308. Epub 2018 Apr 14.
9
Scanning the Immunopathogenesis of Psoriasis.扫描银屑病的免疫发病机制。
Int J Mol Sci. 2018 Jan 8;19(1):179. doi: 10.3390/ijms19010179.
10
A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis.简要探讨趋化因子单核细胞蛋白-1(CCL2)在银屑病病理生理学中的作用。
Cytokine. 2018 Oct;110:226-231. doi: 10.1016/j.cyto.2017.12.010. Epub 2017 Dec 23.